These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 27720639

  • 1. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
    Yoon MS, Pham CT, Phan MT, Shin DJ, Jang YY, Park MH, Kim SK, Kim S, Cho D.
    Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
    [Abstract] [Full Text] [Related]

  • 2. [Expressions of CXCL16/CXCR6 and CXCL12/CXCR4 in first-trimester human trophoblast cells].
    Huang Y, Li DJ, Wang MY, Cheng HD.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):399-402. PubMed ID: 16831364
    [Abstract] [Full Text] [Related]

  • 3. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G, Wang X, Wang J, Zu L, Cheng G, Hao M, Sun X, Xue Y, Lu J, Wang J.
    Oncotarget; 2015 Jun 10; 6(16):14165-78. PubMed ID: 25909173
    [Abstract] [Full Text] [Related]

  • 4. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts.
    Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.
    Clin Exp Immunol; 2007 Jul 10; 149(1):146-54. PubMed ID: 17459077
    [Abstract] [Full Text] [Related]

  • 5. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
    Na KY, Kim HS, Jung WW, Sung JY, Kalil RK, Kim YW, Park YK.
    Hum Pathol; 2014 Apr 10; 45(4):753-60. PubMed ID: 24507753
    [Abstract] [Full Text] [Related]

  • 6. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
    Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O.
    J Immunol; 2003 Feb 01; 170(3):1136-40. PubMed ID: 12538668
    [Abstract] [Full Text] [Related]

  • 7. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L, Cui ZM, Zhang J, Huang Y.
    Chin J Cancer; 2011 May 01; 30(5):336-43. PubMed ID: 21527066
    [Abstract] [Full Text] [Related]

  • 8. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
    Hu W, Liu Y, Zhou W, Si L, Ren L.
    PLoS One; 2014 May 01; 9(6):e99056. PubMed ID: 24897301
    [Abstract] [Full Text] [Related]

  • 9. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
    Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YY, Maeda S, Stein I, Singh SP, Bedolla RB, Peled A, Troyer DA, Pikarsky E, Karin M, Farber JM.
    PLoS One; 2009 Aug 19; 4(8):e6695. PubMed ID: 19690611
    [Abstract] [Full Text] [Related]

  • 10. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
    Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E.
    Cancer Res; 2008 Jun 15; 68(12):4701-8. PubMed ID: 18559516
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
    Hald SM, Kiselev Y, Al-Saad S, Richardsen E, Johannessen C, Eilertsen M, Kilvaer TK, Al-Shibli K, Andersen S, Busund LT, Bremnes RM, Donnem T.
    BMC Cancer; 2015 May 29; 15():441. PubMed ID: 26021984
    [Abstract] [Full Text] [Related]

  • 13. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
    Hu W, Zhen X, Xiong B, Wang B, Zhang W, Zhou W.
    Cancer Sci; 2008 Jul 29; 99(7):1362-9. PubMed ID: 18452560
    [Abstract] [Full Text] [Related]

  • 14. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
    Diegelmann J, Seiderer J, Niess JH, Haller D, Göke B, Reinecker HC, Brand S.
    Inflamm Bowel Dis; 2010 Nov 29; 16(11):1871-81. PubMed ID: 20848509
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
    Deng L, Chen N, Li Y, Zheng H, Lei Q.
    Biochim Biophys Acta; 2010 Aug 29; 1806(1):42-9. PubMed ID: 20122997
    [Abstract] [Full Text] [Related]

  • 17. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer.
    Huang Y, Zhang J, Cui ZM, Zhao J, Zheng Y.
    Chin J Cancer; 2013 May 29; 32(5):289-96. PubMed ID: 22958742
    [Abstract] [Full Text] [Related]

  • 18. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.
    Rabquer BJ, Tsou PS, Hou Y, Thirunavukkarasu E, Haines GK, Impens AJ, Phillips K, Kahaleh B, Seibold JR, Koch AE.
    Arthritis Res Ther; 2011 Feb 08; 13(1):R18. PubMed ID: 21303517
    [Abstract] [Full Text] [Related]

  • 19. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.
    Gooden MJ, Wiersma VR, Boerma A, Leffers N, Boezen HM, ten Hoor KA, Hollema H, Walenkamp AM, Daemen T, Nijman HW, Bremer E.
    Br J Cancer; 2014 Mar 18; 110(6):1535-44. PubMed ID: 24518602
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.